BioCentury | Jun 27, 2019
Distillery Therapeutics

Ketorolac and resolvins to prevent cancer recurrence

...cserhan@bwh.harvard.edu CONTACT: Vikas P. Sukhatme, Emory University, Atlanta, Ga. email: vsukhatme@emory.edu Claire Quang Acular LS (acuvail 0.45%, ketorolac tromethamine) Emory...
BioCentury | Dec 8, 2018
Regulation

Path to opioid-free pain relief

...compared to those receiving placebo (47 mg and 56 mg, respectively)." Egalet Corp. (NASDAQ:EGLT) Sprix ketorolac tromethamine...
...level “The clinical relevance of this is reflected in the finding that patients treated with SPRIX...
BioCentury | Sep 5, 2016
Financial News

Egalet completes private placement of senior notes

...1.5% royalty payment on net sales of Egalet’s marketed pain drugs, Oxaydo oxycodone and Sprix ketorolac tromethamine. WIR...
BioCentury | Jan 12, 2015
Company News

Daiichi Sankyo, Egalet deal

...Egalet purchased Sprix ketorolac tromethamine nasal spray from Daiichi Sankyo’s Luitpold Pharmaceuticals Inc. subsidiary for $7 million...
...require analgesia at the opioid level. Luitpold will begin promotion of the product this quarter. Sprix...
BioCentury | Jul 9, 2012
Clinical News

Sprix ketorolac tromethamine update

...Pharmaceuticals Inc. company said a group of academic researchers began the AMPED registry to evaluate Sprix...
...without oral narcotics, or oral narcotics alone in patients seeking emergency medical care for pain. Sprix...
...Luitpold in 2010. Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Sprix ketorolac tromethamine ( ROX-888...
BioCentury | May 23, 2011
Company News

Luitpold Pharmaceuticals Inc., Daiichi Sankyo sales and marketing update

...Luitpold's Regency Therapeutics division and Daiichi Sankyo launched Sprix ketorolac tromethamine nasal spray in the U.S. to...
...The wholesale acquisition price is $137.50 per box of five 126 mg single-day spray bottles. Sprix...
BioCentury | May 24, 2010
Clinical News

Sprix regulatory update

...FDA approved an NDA from Roxro for Sprix ketorolac tromethamine nasal spray for short-term management of acute...
...commercialization partner for the analgesic. Roxro Pharma Inc. , Menlo Park, Calif. Product: Sprix ( ROX-888...
BioCentury | May 18, 2010
Company News

FDA approves Roxro's Sprix

...FDA approved an NDA from Roxro Pharma Inc. (Menlo Park, Calif.) for Sprix ketorolac tromethamine nasal spray...
BioCentury | Jul 27, 2009
Clinical News

Acuvail 0 regulatory update

...Allergan said FDA approved an NDA for Acuvail ketorolac tromethamine ophthalmic solution to treat pain and inflammation...
...a non-steroidal anti-inflammatory drug (NSAID), in September. Allergan Inc. (NYSE:AGN), Irvine, Calif. Product: Acuvail 0.45% ketorolac tromethamine...
BioCentury | Feb 9, 2009
Clinical News

ROX-888 regulatory update

...Roxro said FDA accepted for filing an NDA for ROX-888 for the management of acute moderate-to-severe...
...launch, which is expected by year end. Roxro Pharma Inc. , Menlo Park, Calif. Product: ROX-888...
Items per page:
1 - 10 of 17